NEWS RELEASE
PUBLICATIONS
A novel automated microchip flow-chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions
The first paper on T-TAS system’s concept verification study.
T-TAS instrument and AR chip’s assay principle are explained.
リンク
A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process
T-TAS instrument and PL chip’s assay principle are explained.
It was suggested that T-TAS can distinguish the pharmacological effects of various antiplatelet drugs under physiological shear rates.
リンク
Total Thrombus-Formation Analysis System(T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease
The paper describes the role of T-TAS in cardiovascular disease.
The author concludes that T-TAS is a useful index for evaluating the total antithrombotic effects of combination antithrombotic agents in patients with various cardiovascular diseases.
リンク
A modified microchip-based flow chamber system for evaluating thrombogenicity in patients with thrombocytopenia
The first paper on the T-TAS 01 HD assay.
The thrombogenic potential of thrombocytopenic patients before and after platelet transfusion was assessed with T-TAS HD assay.
HD assay results reflected the hemostatic function of patients with thrombocytopenita.
リンク
CATEGORIES
LITERATURE DATABASE
CONCEPT

Mission
Contribute to the worldwide development of medical treatment and the realization of a healthy society by developing and providing CHIGAI (differentiation) technologies, products and services.

Target
Create and expand our medical business as a new business pillar for Fujimori’s Next100.

Concept
Generate and expand our business in the targeted field by creating the “Only One” values (i.e., technology, products and services).